Armistice Capital, LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-27 6:02 pm Sale |
2023-06-26 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 2,597 4.990% |
-17,331 (-86.97%) |
Filing |
| 2023-02-09 4:27 pm Purchase |
2023-02-07 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 19,928 35.400% |
1,876 (+10.39%) |
Filing |
| 2022-08-11 4:09 pm Sale |
2022-08-08 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 18,052 44.400% |
-0 (-0.00%) |
Filing |
| 2022-03-15 5:16 pm Purchase |
2022-03-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 18,052 44.500% |
408 (+2.31%) |
Filing |
| 2022-01-19 6:41 pm Purchase |
2022-01-18 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,643 43.700% |
486 (+2.83%) |
Filing |
| 2021-12-16 4:04 pm Unchanged |
2021-12-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,157 42.500% |
0 (Unchanged) |
Filing |
| 2021-11-08 4:05 pm Unchanged |
2021-11-04 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,157 43.900% |
0 (Unchanged) |
Filing |
| 2021-10-14 9:01 pm Purchase |
2021-10-14 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,157 43.900% |
143 (+0.84%) |
Filing |
| 2021-09-17 3:04 pm Purchase |
2021-09-17 | 13D | Avalo Therapeutics, Inc. AVTX |
Armistice Capital, LLC | 17,014 43.900% |
17,014 (New Position) |
Filing |